nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ORM1—bile—gallbladder cancer	0.0884	0.212	CbGeAlD
Tacrolimus—ABCA5—pancreas—gallbladder cancer	0.0322	0.0772	CbGeAlD
Tacrolimus—ORM1—gall bladder—gallbladder cancer	0.0245	0.0588	CbGeAlD
Tacrolimus—PPP3CA—pancreas—gallbladder cancer	0.0217	0.0521	CbGeAlD
Tacrolimus—ALB—gall bladder—gallbladder cancer	0.0215	0.0516	CbGeAlD
Tacrolimus—ABCA5—liver—gallbladder cancer	0.0205	0.0491	CbGeAlD
Tacrolimus—MTOR—epithelium—gallbladder cancer	0.018	0.0432	CbGeAlD
Tacrolimus—FKBP1A—epithelium—gallbladder cancer	0.0162	0.0389	CbGeAlD
Tacrolimus—MTOR—pancreas—gallbladder cancer	0.0161	0.0385	CbGeAlD
Tacrolimus—ABCA5—lymph node—gallbladder cancer	0.0157	0.0376	CbGeAlD
Tacrolimus—FKBP1A—pancreas—gallbladder cancer	0.0144	0.0346	CbGeAlD
Tacrolimus—PPP3CA—liver—gallbladder cancer	0.0138	0.0332	CbGeAlD
Tacrolimus—CYP3A7—liver—gallbladder cancer	0.0114	0.0273	CbGeAlD
Tacrolimus—PPP3CA—lymph node—gallbladder cancer	0.0106	0.0254	CbGeAlD
Tacrolimus—MTOR—liver—gallbladder cancer	0.0102	0.0245	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—liver—gallbladder cancer	0.00967	0.0232	CbGeAlD
Tacrolimus—FKBP1A—liver—gallbladder cancer	0.00919	0.022	CbGeAlD
Tacrolimus—MTOR—lymph node—gallbladder cancer	0.00783	0.0188	CbGeAlD
Tacrolimus—ORM1—liver—gallbladder cancer	0.00719	0.0173	CbGeAlD
Tacrolimus—FKBP1A—lymph node—gallbladder cancer	0.00705	0.0169	CbGeAlD
Tacrolimus—ALB—liver—gallbladder cancer	0.00631	0.0151	CbGeAlD
Tacrolimus—CYP3A5—pancreas—gallbladder cancer	0.00629	0.0151	CbGeAlD
Tacrolimus—ORM1—lymph node—gallbladder cancer	0.00552	0.0132	CbGeAlD
Tacrolimus—ALB—lymph node—gallbladder cancer	0.00484	0.0116	CbGeAlD
Tacrolimus—CYP3A5—liver—gallbladder cancer	0.004	0.0096	CbGeAlD
Tacrolimus—ABCB1—epithelium—gallbladder cancer	0.00375	0.00899	CbGeAlD
Tacrolimus—ABCB1—pancreas—gallbladder cancer	0.00334	0.00801	CbGeAlD
Tacrolimus—CYP3A4—liver—gallbladder cancer	0.003	0.0072	CbGeAlD
Tacrolimus—ABCB1—liver—gallbladder cancer	0.00213	0.0051	CbGeAlD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—KRAS—gallbladder cancer	0.00186	0.0032	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—KEAP1—gallbladder cancer	0.00185	0.00317	CbGpPWpGaD
Tacrolimus—MTOR—mTOR signaling pathway—KRAS—gallbladder cancer	0.00184	0.00316	CbGpPWpGaD
Tacrolimus—MTOR—ErbB Signaling Pathway—HRAS—gallbladder cancer	0.00184	0.00315	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TP53—gallbladder cancer	0.00183	0.00313	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—ERBB3—gallbladder cancer	0.00181	0.00311	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB3—gallbladder cancer	0.0018	0.00309	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00178	0.00305	CbGpPWpGaD
Tacrolimus—MTOR—IRS-mediated signalling—NRAS—gallbladder cancer	0.00175	0.003	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—NRAS—gallbladder cancer	0.0017	0.00291	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—NRAS—gallbladder cancer	0.00168	0.00289	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—gallbladder cancer	0.00166	0.00284	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—NRAS—gallbladder cancer	0.00164	0.00281	CbGpPWpGaD
Tacrolimus—MTOR—Insulin receptor signalling cascade—NRAS—gallbladder cancer	0.00164	0.00281	CbGpPWpGaD
Tacrolimus—ABCB1—lymph node—gallbladder cancer	0.00163	0.00391	CbGeAlD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.00163	0.0028	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—ERBB4—gallbladder cancer	0.0016	0.00275	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—HRAS—gallbladder cancer	0.00158	0.00272	CbGpPWpGaD
Tacrolimus—MTOR—AMPK Signaling—TP53—gallbladder cancer	0.00158	0.00271	CbGpPWpGaD
Tacrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—EGFR—gallbladder cancer	0.00158	0.0027	CbGpPWpGaD
Tacrolimus—MTOR—mTOR signaling pathway—HRAS—gallbladder cancer	0.00156	0.00268	CbGpPWpGaD
Tacrolimus—MTOR—TSH signaling pathway—HRAS—gallbladder cancer	0.00156	0.00268	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.00153	0.00263	CbGpPWpGaD
Tacrolimus—MTOR—IRS-mediated signalling—KRAS—gallbladder cancer	0.0015	0.00258	CbGpPWpGaD
Tacrolimus—MTOR—CDC42 signaling events—HRAS—gallbladder cancer	0.00149	0.00256	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.00149	0.00256	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00148	0.00254	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—NRAS—gallbladder cancer	0.00148	0.00253	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	0.00147	0.00251	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—KRAS—gallbladder cancer	0.00146	0.00251	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—NRAS—gallbladder cancer	0.00145	0.00249	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—KRAS—gallbladder cancer	0.00145	0.00249	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—ERBB2—gallbladder cancer	0.00144	0.00247	CbGpPWpGaD
Tacrolimus—MTOR—PI-3K cascade—EGFR—gallbladder cancer	0.00142	0.00244	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—HRAS—gallbladder cancer	0.00141	0.00242	CbGpPWpGaD
Tacrolimus—MTOR—Insulin receptor signalling cascade—KRAS—gallbladder cancer	0.00141	0.00242	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—KRAS—gallbladder cancer	0.00141	0.00242	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.0014	0.0024	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—ERBB3—gallbladder cancer	0.00139	0.00238	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—EGFR—gallbladder cancer	0.00139	0.00238	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—ERBB2—gallbladder cancer	0.00138	0.00236	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—EGFR—gallbladder cancer	0.00138	0.00236	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—NRAS—gallbladder cancer	0.00137	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.00137	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—ERBB2—gallbladder cancer	0.00137	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—ERBB2—gallbladder cancer	0.00136	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—NRAS—gallbladder cancer	0.00136	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—ERBB2—gallbladder cancer	0.00136	0.00233	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.00134	0.00231	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—gallbladder cancer	0.00134	0.00231	CbGpPWpGaD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—gallbladder cancer	0.00134	0.0023	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—gallbladder cancer	0.00134	0.00229	CbGpPWpGaD
Tacrolimus—MTOR—IRS-mediated signalling—HRAS—gallbladder cancer	0.00128	0.00219	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.00128	0.00219	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—ERBB2—gallbladder cancer	0.00128	0.00219	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.00128	0.00219	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.00127	0.00218	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—ERBB2—gallbladder cancer	0.00127	0.00217	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.00125	0.00215	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	0.00125	0.00215	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—ERBB2—gallbladder cancer	0.00125	0.00214	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00124	0.00213	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—HRAS—gallbladder cancer	0.00124	0.00213	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—gallbladder cancer	0.00123	0.00211	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ERBB4—gallbladder cancer	0.00122	0.0021	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—HRAS—gallbladder cancer	0.0012	0.00206	CbGpPWpGaD
Tacrolimus—MTOR—Insulin receptor signalling cascade—HRAS—gallbladder cancer	0.0012	0.00206	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—ERBB2—gallbladder cancer	0.00118	0.00203	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—KRAS—gallbladder cancer	0.00118	0.00202	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—KRAS—gallbladder cancer	0.00117	0.00201	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—BCL2—gallbladder cancer	0.00117	0.00201	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.00117	0.002	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—ERBB2—gallbladder cancer	0.00114	0.00195	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	0.00113	0.00194	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—ERBB4—gallbladder cancer	0.00113	0.00194	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—gallbladder cancer	0.00113	0.00194	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KEAP1—gallbladder cancer	0.00112	0.00192	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	0.00111	0.00191	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—NRAS—gallbladder cancer	0.0011	0.00188	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.00108	0.00185	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—gallbladder cancer	0.00108	0.00185	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.00106	0.00182	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.00106	0.00182	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ERBB3—gallbladder cancer	0.00106	0.00181	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—NRAS—gallbladder cancer	0.00105	0.0018	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—NRAS—gallbladder cancer	0.00104	0.00179	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—NRAS—gallbladder cancer	0.00104	0.00178	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—NRAS—gallbladder cancer	0.00103	0.00177	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	0.00102	0.00175	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.00102	0.00174	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.001	0.00172	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—HRAS—gallbladder cancer	0.001	0.00172	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.001	0.00172	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—EGFR—gallbladder cancer	0.001	0.00171	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—HRAS—gallbladder cancer	0.000997	0.00171	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—ERBB3—gallbladder cancer	0.000976	0.00167	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—NRAS—gallbladder cancer	0.000971	0.00167	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.000971	0.00167	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.000971	0.00167	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—NRAS—gallbladder cancer	0.000963	0.00165	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.00096	0.00165	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—EGFR—gallbladder cancer	0.000955	0.00164	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.000954	0.00164	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—EGFR—gallbladder cancer	0.00095	0.00163	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.00095	0.00163	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—NRAS—gallbladder cancer	0.00095	0.00163	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.000949	0.00163	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—EGFR—gallbladder cancer	0.000945	0.00162	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—KRAS—gallbladder cancer	0.000944	0.00162	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—EGFR—gallbladder cancer	0.000941	0.00161	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	0.000927	0.00159	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—ERBB4—gallbladder cancer	0.000915	0.00157	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—KRAS—gallbladder cancer	0.000902	0.00155	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—NRAS—gallbladder cancer	0.000899	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—KRAS—gallbladder cancer	0.000897	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000897	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—KRAS—gallbladder cancer	0.000893	0.00153	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—KRAS—gallbladder cancer	0.000889	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000885	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—EGFR—gallbladder cancer	0.000885	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.000885	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ERBB4—gallbladder cancer	0.000879	0.00151	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—EGFR—gallbladder cancer	0.000877	0.0015	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.000876	0.0015	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ERBB4—gallbladder cancer	0.000875	0.0015	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—ERBB2—gallbladder cancer	0.00087	0.00149	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000869	0.00149	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—EGFR—gallbladder cancer	0.000866	0.00148	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—NRAS—gallbladder cancer	0.000866	0.00148	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.00086	0.00148	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.000852	0.00146	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.000844	0.00145	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—HRAS—gallbladder cancer	0.000838	0.00144	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000836	0.00143	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—KRAS—gallbladder cancer	0.000836	0.00143	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000836	0.00143	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—KRAS—gallbladder cancer	0.000829	0.00142	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000821	0.00141	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—EGFR—gallbladder cancer	0.000819	0.0014	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—KRAS—gallbladder cancer	0.000818	0.0014	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000816	0.0014	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—gallbladder cancer	0.000804	0.00138	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—HRAS—gallbladder cancer	0.000803	0.00138	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—ERBB3—gallbladder cancer	0.000791	0.00136	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB4—gallbladder cancer	0.00079	0.00136	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—EGFR—gallbladder cancer	0.000789	0.00135	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000784	0.00134	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—KRAS—gallbladder cancer	0.000774	0.00133	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—HRAS—gallbladder cancer	0.00077	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—HRAS—gallbladder cancer	0.000767	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000763	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—HRAS—gallbladder cancer	0.000763	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ERBB3—gallbladder cancer	0.00076	0.0013	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—HRAS—gallbladder cancer	0.000759	0.0013	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ERBB3—gallbladder cancer	0.000757	0.0013	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—HRAS—gallbladder cancer	0.000755	0.0013	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—KRAS—gallbladder cancer	0.000745	0.00128	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.000745	0.00128	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000741	0.00127	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000711	0.00122	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000711	0.00122	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—HRAS—gallbladder cancer	0.000711	0.00122	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—HRAS—gallbladder cancer	0.000704	0.00121	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000698	0.0012	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—HRAS—gallbladder cancer	0.000695	0.00119	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB3—gallbladder cancer	0.000683	0.00117	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—BCL2—gallbladder cancer	0.000682	0.00117	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ERBB2—gallbladder cancer	0.000663	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—NRAS—gallbladder cancer	0.000662	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—HRAS—gallbladder cancer	0.000658	0.00113	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—HRAS—gallbladder cancer	0.000633	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000629	0.00108	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB4—gallbladder cancer	0.000613	0.00105	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—ERBB2—gallbladder cancer	0.000612	0.00105	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—EGFR—gallbladder cancer	0.000603	0.00103	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—KRAS—gallbladder cancer	0.00057	0.000977	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—NRAS—gallbladder cancer	0.000552	0.000946	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—gallbladder cancer	0.00054	0.000926	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB4—gallbladder cancer	0.000533	0.000914	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000532	0.000913	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB3—gallbladder cancer	0.00053	0.000909	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000517	0.000887	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—BCL2—gallbladder cancer	0.000511	0.000876	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—NRAS—gallbladder cancer	0.000504	0.000865	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—EGFR—gallbladder cancer	0.000503	0.000862	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—ERBB2—gallbladder cancer	0.000496	0.000851	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB4—gallbladder cancer	0.000492	0.000844	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—HRAS—gallbladder cancer	0.000484	0.00083	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ERBB2—gallbladder cancer	0.000476	0.000817	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—KRAS—gallbladder cancer	0.000475	0.000815	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ERBB2—gallbladder cancer	0.000474	0.000814	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NRAS—gallbladder cancer	0.000465	0.000798	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB3—gallbladder cancer	0.000461	0.00079	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EGFR—gallbladder cancer	0.000459	0.000788	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—KRAS—gallbladder cancer	0.000434	0.000744	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB2—gallbladder cancer	0.000428	0.000735	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB3—gallbladder cancer	0.000425	0.00073	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—EGFR—gallbladder cancer	0.000424	0.000727	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—HRAS—gallbladder cancer	0.000404	0.000692	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—KRAS—gallbladder cancer	0.000401	0.000687	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—NRAS—gallbladder cancer	0.000377	0.000647	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HRAS—gallbladder cancer	0.000369	0.000633	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—NRAS—gallbladder cancer	0.000362	0.000622	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NRAS—gallbladder cancer	0.000361	0.000619	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000359	0.000615	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB4—gallbladder cancer	0.000345	0.000591	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EGFR—gallbladder cancer	0.000344	0.00059	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HRAS—gallbladder cancer	0.00034	0.000584	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000339	0.000581	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB2—gallbladder cancer	0.000332	0.00057	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—EGFR—gallbladder cancer	0.00033	0.000566	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EGFR—gallbladder cancer	0.000329	0.000564	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NRAS—gallbladder cancer	0.000326	0.000559	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—KRAS—gallbladder cancer	0.000325	0.000557	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—KRAS—gallbladder cancer	0.000312	0.000535	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—KRAS—gallbladder cancer	0.000311	0.000533	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000301	0.000516	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB3—gallbladder cancer	0.000298	0.000511	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—BCL2—gallbladder cancer	0.000297	0.00051	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EGFR—gallbladder cancer	0.000297	0.000509	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB2—gallbladder cancer	0.000289	0.000496	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KRAS—gallbladder cancer	0.000281	0.000481	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—HRAS—gallbladder cancer	0.000276	0.000474	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB2—gallbladder cancer	0.000267	0.000458	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HRAS—gallbladder cancer	0.000265	0.000455	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HRAS—gallbladder cancer	0.000264	0.000453	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NRAS—gallbladder cancer	0.000253	0.000433	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—gallbladder cancer	0.000249	0.000428	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HRAS—gallbladder cancer	0.000238	0.000409	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EGFR—gallbladder cancer	0.00023	0.000395	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NRAS—gallbladder cancer	0.00022	0.000377	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KRAS—gallbladder cancer	0.000218	0.000373	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NRAS—gallbladder cancer	0.000206	0.000353	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NRAS—gallbladder cancer	0.000203	0.000348	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EGFR—gallbladder cancer	0.0002	0.000344	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—gallbladder cancer	0.000193	0.000332	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KRAS—gallbladder cancer	0.000189	0.000325	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB2—gallbladder cancer	0.000187	0.00032	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EGFR—gallbladder cancer	0.000185	0.000317	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HRAS—gallbladder cancer	0.000185	0.000317	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—KRAS—gallbladder cancer	0.000177	0.000304	CbGpPWpGaD
Tacrolimus—MTOR—Disease—KRAS—gallbladder cancer	0.000175	0.0003	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HRAS—gallbladder cancer	0.000161	0.000276	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—gallbladder cancer	0.000158	0.00027	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HRAS—gallbladder cancer	0.000151	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HRAS—gallbladder cancer	0.000148	0.000255	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NRAS—gallbladder cancer	0.000142	0.000244	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EGFR—gallbladder cancer	0.000129	0.000222	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KRAS—gallbladder cancer	0.000122	0.00021	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—gallbladder cancer	0.000109	0.000186	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HRAS—gallbladder cancer	0.000104	0.000178	CbGpPWpGaD
